To further investigate such a developing pathway, we profiled the downstream genes of miR-200b through miRWalk, of which IGF2BP2 stood out as a potential target involved in the regulating pathway of ESCC. This evidence concerns the gene IGF2BP2 and esophageal squamous cell carcinoma.